Noopept Capsules
Noopept Capsules USA — Capsules
Nootropic Dipeptide
Also known as GVS-111 / N-phenylacetyl-L-prolylglycine ethyl ester
Noopept is a synthetic proline-containing dipeptide studied in research for nootropic and neuroprotective activity.
Discount and referral codes apply at checkout. Sales, Mix & Match and payment-method discounts don't.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Noopept is a synthetic proline-containing dipeptide studied in research for nootropic and neuroprotective activity.
Experimental models examine its influence on neurotrophic signaling and cognitive-performance endpoints under controlled laboratory conditions.
Third-party tested for purity, ID, quantity.
Coming Soon
The certificate of analysis for this lot is being finalised and will be published here as soon as the lab returns it.
Noopept (GVS-111) is a dipeptide analogue developed from the pyrrolidone nootropic class. Research has examined its neuroprotective behavior, including effects on neurotrophic factor expression and resistance to oxidative and excitotoxic stress in cellular and animal models.
Studies have evaluated cognitive-performance endpoints and downstream signaling such as HIF-1 activation under structured experimental conditions.
Noopept was synthesized during research into peptide analogues of racetam nootropics, intended to reproduce procognitive activity at lower doses.
Subsequent preclinical work characterized its neuroprotective and anti-inflammatory profile across multiple models.
Research into noopept focuses on neuroprotection and cognitive-pathway models. Frameworks evaluate neurotrophic signaling, oxidative-stress resistance, and inflammatory modulation under controlled in vitro and preclinical conditions.
1 of the 4 areas below are addressed directly by a paper cited on this page.
Neuroprotection and neurotrophic signaling models
No paper cited on this page reports on neuroprotection or neurotrophic. This heading marks where Noopept Capsules is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Cognitive-performance research frameworks
Addressed on this page by Zainullina 2020. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Zainullina, LF. et al. (2020) — Cognitive Enhancer Noopept Activates Transcription Factor HIF-1
Oxidative-stress resistance studies
No paper cited on this page reports on oxidative, stress or resistance. This heading marks where Noopept Capsules is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Neuroinflammation modulation investigations
No paper cited on this page reports on neuroinflammation or modulation. This heading marks where Noopept Capsules is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
The references section of this page cites 3 primary papers published between 2002 and 2021 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Noopept Capsules is frequently listed as a peptide by suppliers in this market. It is not one. The structure published on this page is the compound's actual chemistry, and research on it should be read against its own class rather than against peptide literature.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Noopept Capsules, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Noopept Capsules is also referred to as noopept, GVS-111, and technically as GVS-111 / N-phenylacetyl-L-prolylglycine ethyl ester.
Noopept Capsules is commonly described online in connection with sharper focus, better memory and improved mood. In the research literature the same compound is filed under neuroprotection and neurotrophic signaling models, cognitive-performance research frameworks and oxidative-stress resistance studies.
The 3 papers cited on this page, published between 2002 and 2021 describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Every lot of Noopept Capsules is independently assayed before it is released, and the certificate for the lot shipped is published rather than summarised. Where a certificate for a current lot is not yet posted, the lot has not yet been released against it.
Researchers who buy Noopept Capsules in the United States through Eppix Labs receive a batch-labelled vial whose certificate is published against that lot code, so the material can be matched to its analysis rather than to a generic specification.
- Storage
- Cool, dry, away from direct light
- Humidity
- Keep sealed; capsule shells are hygroscopic
- Reconstitution
- Not applicable — supplied pre-measured
- Format
- Oral capsule
Noopept Capsules is supplied in capsule form, which removes the reconstitution step entirely: there is no vehicle to add, no reconstitution volume to record and no post-reconstitution stability window to track. What that leaves a laboratory to control is storage — capsule shells draw moisture from the air, so the container should be kept sealed and dry rather than decanted into an open vessel.
Because the material is already at its labelled quantity per capsule, batch verification carries more weight in this format than it does for powder: there is no point at which the researcher independently confirms mass by weighing. The measured content published for each lot is the figure that answers that question.
- 1 × sealed capsule bottle (10mg per capsule / Single Bottle - Pack of 60), batch-labelled
- Batch documentation for the lot shipped, once its certificate is published
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Laboratory consumables of any kind
- Dosing, administration or protocol guidance of any kind
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of noopept. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process
PubMedRelated
You May Also Like
Triple Receptor Agonist Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.
From$79.99
Dual GLP-1 / GIP Research Peptide Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.
From$39.99
GLP-1 Receptor Agonist Research Peptide Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.
From$59.99
Selective Amylin Receptor Agonist This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
$100.00